Bonus Issues

BAFNA PHARMACEUTICALS LTD.

NSE : BAFNAPHBSE : 532989ISIN CODE : INE878I01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE76.50-0.99 (-1.28 %)
PREV CLOSE ( ) 77.49
OPEN PRICE ( ) 77.50
BID PRICE (QTY) 76.60 (500)
OFFER PRICE (QTY) 77.95 (30)
VOLUME 446
TODAY'S LOW / HIGH ( )76.50 78.00
52 WK LOW / HIGH ( )77.3 125.55
NSE78.350.3 (+0.38 %)
PREV CLOSE( ) 78.05
OPEN PRICE ( ) 76.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 23233
TODAY'S LOW / HIGH( ) 75.90 78.70
52 WK LOW / HIGH ( )76 124.45

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.